Correction to: Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer
-
Published:2020-09-07
Issue:6
Volume:38
Page:1846-1846
-
ISSN:0167-6997
-
Container-title:Investigational New Drugs
-
language:en
-
Short-container-title:Invest New Drugs
Author:
Kondo ShunsukeORCID,
Tajimi Masaomi,
Funai Tomohiko,
Inoue Koichi,
Asou Hiroya,
Ranka Vinay Kumar,
Wacheck Volker,
Doi Toshihiko
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology